Piperazinylimino rifamycins

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

260/235.82

C07D 498/08 (2006.01)

Patent

CA 1057748

ABSTRACT OF THE DISCLOSURE This invention relates to rifamycin derivative of the formula: Image wherein Me represents a methyl group, n represents 3 or 4, g represents 0, 1 or 2; each R represents a lower alkyl group selected from methyl or ethyl substituting a hydrogen atom of a group -CH2-. These compounds are prepared by reacting 3-formylrifamycin SV with an aminopiperazine of the formula: Image wherein n, g and R are as defined above. The novel rifamycin derivatives of the invention are useful because they possess the usual broad spectrum activity perculiar to refamycin derivatives coupled with extremely high activity and low toxicity permitting control of bacertial infections by oral administration with long intervals between doses, for example, it has been found that a single weekly dose will give effective control.

247156

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Piperazinylimino rifamycins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Piperazinylimino rifamycins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperazinylimino rifamycins will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-866626

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.